Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,632 total articles
Pharming Group N.V. announced FDA approval for its drug Joenja® (leniolisib) to treat children aged 4 to 11 years weighing at least 27 kg with activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency. This marks the first FDA approved treatment for younger pediatric APDS patients in the U.S., expanding the indicati…
Greenland Mines Ltd reported substantial progress in its 2026 field programs at the Skaergaard palladium-platinum-gold project and the Sarfartoq rare earth element project in Greenland. At Skaergaard, the company completed an expanded bulk-sampling program, exceeding plans and supporting metallurgical test work. At Sarfartoq, operations commenced s…
Vicor Corporation is acquiring two large industrial sites in Merrimack and Hooksett, New Hampshire, to build ChiP Fab-2 and Fab-3, significantly increasing its power component manufacturing capacity beyond the current Fab-1 in Massachusetts. This expansion aims to support advanced AI applications by providing scalable, high-performance Vertical Pow…
DoubleDown Interactive, a NASDAQ-listed developer of digital games, announced a $10,000 donation to the American Society for the Prevention of Cruelty to Animals (ASPCA). The company is also launching the 'Huggable Hounds' in-game event to promote awareness of the ASPCA's work and engage players in a charitable giveaway. This donation underscores D…
SEALSQ Corp announced strong H1 2026 financial results showing a 131% increase in revenue to $11.2 million and a gross profit increase of 233%. The company reaffirmed its FY2026 revenue guidance of $27 million to $36 million, driven by growth in secure-element products, PKI subscriptions, and initial commercialization of post-quantum semiconductor …
FingerMotion, Inc. has reported significant financial improvements within 30 days of new management taking over, including raising cash to approximately $5.1 million, reducing monthly cash burn by nearly 30%, and terminating its ATM sales agreement to focus on more discrete financing. The company is shifting its strategic focus from China to North …
Futuremain Co., Ltd., a South Korean engineering and IT firm specializing in machinery safety diagnostics, has entered a definitive business combination agreement with US-listed SPAC ChampionsGate Acquisition Corp. The transaction values Futuremain at around $80 million and aims to list the combined entity on Nasdaq, accelerating Futuremain's expan…
Silvercrest Asset Management Group Inc., a Nasdaq-listed ultra-high-net-worth wealth advisor with $25 billion in assets under management, has secured a full MiFID license from the Central Bank of Ireland. This regulatory approval allows Silvercrest to expand its services to ultra-high-net-worth clients and institutional investors across Ireland and…
ICZOOM Group Inc. plans a 5-for-1 share consolidation effective September 15, 2026 to meet Nasdaq Marketplace Rule requirements and maintain its listing. The consolidation will reduce the number of outstanding shares without shareholder action, with trading continuing under the same ticker symbol IZM but with a new CUSIP number. ICZOOM operates a B…
Coffee Holding Co., Inc. announced its third quarter fiscal 2026 results with net sales of $21.7 million, down 9.3% due to declining green coffee prices. However, gross profit increased significantly to $5.4 million driven by favorable inventory positions, tariff refunds, and net gains in trading activity. Operating expenses slightly decreased and …
Reborn Coffee Inc., a Nasdaq-listed specialty coffee retailer, has appointed Edward Park and James Lim to its Board of Directors. These appointments add significant expertise in technology, franchising, branding, and international coffee business management. The expanded board aims to enhance governance and support Reborn Coffee's growth strategy a…
Draganfly Inc. has been awarded a five-year contract by the Government of Canada to supply Low-Cost Tactical Intelligence, Surveillance and Reconnaissance (ISR) Uncrewed Aircraft Systems (UAS) to the Canadian Armed Forces. The initial contract includes 100 systems with options to supply up to an additional 4,900 units. The contract includes support…
Fuel Tech, Inc. announced it has secured multiple contracts valued at approximately $2.8 million to supply advanced air pollution control systems and services for utility and industrial customers, including urea reagent delivery for SCR systems, electrostatic precipitator performance modeling, and SNCR technology demonstration. These recent awards …
Celestica Inc. announced a new leadership structure to support its unprecedented growth trajectory. Mandeep Chawla moves from CFO to a newly created Group President, Global Markets role to drive commercial execution and global expansion, while Todd Ankenmann is promoted to CFO. These changes aim to scale operations effectively and capitalize on gro…
Tessera Defense and Homeland Security Inc., formerly BiomX Inc., has officially changed its corporate name and NYSE American ticker symbol to HLSQ, signaling its full transition into a physical security technology platform. The company offers a unified platform integrating cameras, sensors, AI, and detection technologies to enhance protection of cr…
Antelope Enterprise Holdings Limited announced the pricing of a $6.0 million convertible promissory note to Stratosphere Capital Management, bearing 8% interest with conversion options into common shares at a discounted price. The note has no fixed maturity date, features ownership limitations on conversion, and is intended to provide additional ca…
Quantum BioPharma Ltd., trading on NASDAQ as QNTM, announced FDA clearance to initiate phase 2 clinical trials of Lucid-MS, an innovative first-in-class drug candidate aimed at protecting and potentially repairing the myelin sheath in multiple sclerosis patients. The drug represents a novel approach distinct from existing treatments by attempting t…
Moleculin Biotech has released an on-demand webcast of its presentation at the H.C. Wainwright 28th Annual Global Investment Conference, providing an overview of recent corporate and clinical advancements. The company is advancing its lead candidate Annamycin through pivotal Phase 2/3 trials for relapsed or refractory AML and soft tissue sarcoma lu…
Our Bond, Inc. (NASDAQ: OBAI) has partnered with Watson Realty Corp., a major residential real estate brokerage in Florida and Georgia, to provide Bond’s AI-powered Preventative Personal Security platform to all 800 Watson agents companywide. This rollout coincides with REALTOR® Safety Month and aims to address safety concerns for real estate profe…
Allarity Therapeutics, a clinical-stage biotechnology company focused on personalized cancer treatments, has launched a SPAC, Allarity Acquisition Corp., and filed a registration statement with the SEC for an initial public offering expected to raise $100-$115 million. The SPAC will seek a business combination in any industry, and will be listed on…
Apollo Global Management announced that CEO Marc Rowan will participate in a fireside chat at the Bank of America 31st Annual Financials CEO Conference. The event will be webcast live, highlighting Apollo's position as a global alternative asset manager with over $1 trillion in assets under management.
Columbus Acquisition Corp, a US-based special purpose acquisition company (SPAC), announced that it adjourned its Extraordinary General Meeting without conducting any business, including the vote on its proposed business combination with WISeSat.Space Corp. The company will reschedule the meeting and set a new redemption deadline for shareholders. …
GT Biopharma, a clinical stage immuno-oncology company, announced a live presentation on September 11, 2026, detailing clinical progress of its proprietary TriKE® natural killer cell engager platform for cancer treatment. The presentation will cover advancements in treating blood cancers and solid tumors, dosing insights, competitive positioning, a…
Tempest Therapeutics, a clinical-stage biotech company pioneering in vivo CAR-T therapies for cancer and autoimmune diseases, announced a private placement of common stock and warrants to raise up to $7.5 million. The initial gross proceeds from the offering are expected to be approximately $2.5 million, with potential additional proceeds of $5 mil…
Click Holdings Limited's CEO purchased 48,200 shares in the open market, reflecting his commitment to the company's long-term strategy targeting approximately HK$500 million in annual revenue. The company continues to focus on organic growth, strategic initiatives, and potential mergers and acquisitions in its AI-powered HR and senior care services…
